These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 358473)
41. [Therapy of chronic viral hepatitis with interferon]. Niederau C; Heintges T Internist (Berl); 1994 Jan; 35(1):70-7; discussion 77-9. PubMed ID: 7511573 [No Abstract] [Full Text] [Related]
42. Is it true what they say about interferon? Weimar W; Schellekens H N Engl J Med; 1979 Apr; 300(16):923-4. PubMed ID: 423945 [No Abstract] [Full Text] [Related]
44. Purification of human fibroblast interferon prepared from modified fibroblasts. Tan YH Methods Enzymol; 1981; 78(Pt A):422-30. PubMed ID: 6173624 [No Abstract] [Full Text] [Related]
45. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Blalock JE; Georgiades JA; Langford MP; Johnson HM Cell Immunol; 1980 Feb; 49(2):390-4. PubMed ID: 6986204 [No Abstract] [Full Text] [Related]
46. Clinical trials with exogenous interferon: summary of a meeting. Dunnick JK; Galasso GJ J Infect Dis; 1979 Jan; 139(1):109-23. PubMed ID: 220327 [No Abstract] [Full Text] [Related]
47. [Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Alekberova ZS; Barinskiĭ IF; Savinov VA; Pitenov VA; Kuznetsov VP Ter Arkh; 1980; 52(6):98-100. PubMed ID: 6157213 [No Abstract] [Full Text] [Related]
48. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Hadziyannis SJ; Laras A; Hadziyannis E Aliment Pharmacol Ther; 2014 May; 39(10):1250-1. PubMed ID: 24735152 [No Abstract] [Full Text] [Related]
49. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan. Kataoka T; Sakurai Y; Ida N; Kobayashi S Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536 [No Abstract] [Full Text] [Related]
50. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply. Galmozzi E; Viganò M; Lampertico P Aliment Pharmacol Ther; 2014 May; 39(10):1251-2. PubMed ID: 24735153 [No Abstract] [Full Text] [Related]
55. Tolerability of pure fibroblast interferon in man. Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288 [No Abstract] [Full Text] [Related]